A dipeptidyl peptidase-4 (DPP-4) inhibitor, linagliptin, attenuates cardiac dysfunction after myocardial infarction independently of DPP-4

Yamaguchi, T; Watanabe, A; Tanaka, M; Shiota, M; Osada-Oka, M; Sano, S; Yoshiyama, M; Miura, K; Kitajima, S; Matsunaga, S; Tomita, S; Iwao, H; Izumi, Y

Yamaguchi, T (reprint author), Osaka City Univ, Dept Pharmacol, Grad Sch Med, Abeno Ku, 1-4-3 Asahimachi, Osaka 5458585, Japan.

JOURNAL OF PHARMACOLOGICAL SCIENCES, 2019; 139 (2): 112

Abstract

Dipeptidyl peptidase-4 (DPP-4) inhibitors not only improve impaired glucose tolerance in diabetes, but also have pleiotropic extra-pancreatic effects ......

Full Text Link